Two members of the KDM3 group, KDM3A and KDM3C, represent the most promising therapeutic targets for colorectal cancers (CRC) [71,72] and a subtype of acute leukemia, respectively [73]. The gene discussed is KDM3A; the disease is colorectal carcinoma.